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Background: Themaintenance of cellmetabolismand homeostasis is a fundamental characteristic of living organ-
isms. In eukaryotes,mitochondria are the cornerstone of these life supporting processes, playing leading roles in a
host of core cellular functions, including energy transduction, metabolic and calcium signalling, and supporting
roles in a number of biosynthetic pathways. The possession of a discrete mitochondrial genome dictates that
themaintenance ofmitochondrial ‘ﬁtness’ requires quality controlmechanismswhich involve close communica-
tion with the nucleus.
Scope of review: This review explores the synergistic mechanisms that control mitochondrial quality and function
and ensure cellular bioenergetic homeostasis. These include antioxidant defence mechanisms that protect against
oxidative damage caused by reactive oxygen species, while regulating signals transduced through such free radicals.
Proteinhomeostasis controls import, folding, anddegradationof proteins underpinnedbymechanisms that regulate
bioenergetic capacity through the mitochondrial unfolded protein response. Autophagic machinery is recruited for
mitochondrial turnover through the process of mitophagy. Mitochondria also communicate with the nucleus to
exact speciﬁc transcriptional responses through retrograde signalling pathways.
Major conclusions: The outcome of mitochondrial quality control is not only reliant on the efﬁcient operation of the
core homeostatic mechanisms but also in the effective interaction of mitochondria with other cellular components,
namely the nucleus.
General signiﬁcance: Understanding mitochondrial quality control and the interactions between the organelle and
the nucleus will be crucial in developing therapies for the plethora of diseases in which the pathophysiology is de-
termined by mitochondrial dysfunction. This article is part of a Special Issue entitled Frontiers of Mitochondrial
Research.© 2013 The Authors. Published by Elsevier B.V. All rights reserved.1. Introduction—mitochondrial functionandﬁtness are fundamental
to cellular health
Mitochondria are critical cellular organelles best known for their role
in providing efﬁcient energetic support through the chemiosmotic pro-
cess of oxidative phosphorylation (OXPHOS). Although mitochondria
were ﬁrst observed in the latter part of the 19th century, their role in
aerobic energy transduction through the characteristic chemiosmotic
mechanism of OXPHOS ﬁrst began to be clariﬁed in the 1960s [1].
Since then, mitochondria have also been shown to perform a variety
of roles in processes such as the transduction of metabolic and stress
signals [2,3], the production of free radicals such as reactive oxygenerms of the Creative Commons
bution, and reproduction in any
ed.
s of Mitochondrial Research.
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ame).
lished by Elsevier B.V. All rights reserspecies (ROS) [4], and the induction of programmed cell death [3]. Cen-
tral to cellular bioenergetic homeostasis is the requirement to sustain
the mitochondrial population to ensure that cellular energy demands
are met by energy supply. A variety of quality control (QC) mechanisms
have evolved which ensure cellular bioenergetic homeostasis, manag-
ing mitochondrial components, products and by-products. Dysregula-
tion of these pathways is emerging as a key theme in understanding
many contemporary human diseases. Thus, it is increasingly clear that
mitochondrial dysfunction and disordered regulation of mitochondrial
homeostasis play integral roles in the pathophysiology of conditions
such as cancer [5], neurodegeneration [6], as well as ageing [7]. In addi-
tion, dysfunction of mitochondria caused by mutations in genes coding
for the organelle components typiﬁes a distinctive class of conditions
known as mitochondrial diseases [8].
Mitochondrial structure is characterised by two protein containing
lipid bilayers. The main compartments of the organelle are the external
outer mitochondrial membrane (OMM), the inter membrane space
(IMS) and the matrix, which is enclosed by the inner mitochondrial
membrane (IMM) that undergoes intense folding into cristae, which
vastly expand the membrane surface area. The electron transportved.
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generate the proton gradient across the IMM that delivers the crucial
chemiosmotic force of the OXPHOS process. The biochemistry that
underpins the OXPHOS process revolves around a variety of redox reac-
tions, the transfer of electrons between protein complexes, and the
eventual delivery of electrons to molecular oxygen (O2). However,
stray electrons can react prematurely and incompletely with O2 in the
local environment, especially if the respiratory chain is compromised,
leading to the formation of free radicals known as reactive oxygen
species (ROS) [4,9]. Primarily considered dangerous by-products that
can impair the structure and activity of proteins and lipids, ROS also
appear to be essential signalling components of cellular physiology
[10,11]. Nevertheless, production of ROS can lead to the accumulation
of damaged mitochondrial components. Primary cellular defences
against this type of oxidative stress have been resourcefully adapted
so as to detoxify the harmful effects of ROS while maintaining their
signalling capacity.
Loss of activity, misfolding, and aggregation of protein components
due to genetic mutations or environmental stress are important causes
ofmitochondrial dysfunction that lead to deterioration in cellular health
[12–14]. The replenishment of mitochondrial proteins is a complex
process, as it requires the coordinated expression of two genomes, the
nuclear and mitochondrial. The human mitochondrial genome encodes
only 13 proteins, all of which are critical components of the respiratory
chain complexes, as well as two ribosomal subunits and all the tRNAs
required for protein translation [15]. All other mitochondrial proteins
are encoded by the nuclear genome. Formation of the functional
OXPHOS complexes is heavily reliant on a strict stoichiometry of protein
components in order to correctly assemble in the IMM [16]. Hence, the
effective and measured transcription and translation of both genomes
must be coordinated to avoid superﬂuous expression and accumulation
of non-functional proteins within mitochondria. The nuclear genome
also encodes for mitochondrial targeted proteins responsible for regu-
lating mtDNA encoded gene expression and replication, thus playing a
major part in regulating mitochondrial genome function and capacity
[17]. This pathway is complemented by the emerging role of the con-
verse regulation of nuclear gene expression in response to cues originat-
ing from the mitochondria, in a process termed retrograde signalling
[18,19]. Hence, mechanisms of mitochondrial QC include the monitor-
ing and control of components, function, and products, as well as the
communication between mitochondria and other cellular components.
During this review we aim to highlight current understanding of
mitochondrial QC processes as they relate to different aspects of mito-
chondrial structure and function, as well as remarking on various asso-
ciated systems that are essential for QC.
2. Antioxidant defences and the regulation of reactive oxygen
species (ROS)
2.1. The multifaceted ROS— oxidative stress and physiological requirement
for ROS
Oxidative stress is an environmental conditionwhere ROS generated
exceeds the capacity of antioxidant defences in neutralising free
radicals, and thus results in damage caused by the aberrant reactivity
of ROS with cellular components. Oxygen derived free radicals are an
important by-product of the mitochondrial ETC., not only because of
their potential to cause damage, but also because they are thought to
play important signalling roles essential for physiological cellular func-
tion [9,11]. ROS are initially formed by the premature release of elec-
trons from the ETC. and the reduction of molecular oxygen (O2) to
form the superoxide radical (•O2−) [4,9]. Superoxide is thought to be
generated at seven different sites associated with proteins at the IMM,
which mainly generate superoxide on the matrix side of the IMM. Of
these sites, two also release O2− into the IMS [10]. Superoxide has a
very short half-life and is highly reactive, causing damage to vitalmitochondrial components such as mtDNA, lipid membranes and to
respiratory complexes, all ofwhich are locatednear the sites of superox-
ide production [9,10]. Superoxide can then be transformed into other
free radical species via enzymatic catalysis mediated by superoxide
dismutases that generate hydrogen peroxide (H2O2), by iron (Fe)medi-
ated chemistry forming the highly reactive hydroxyl radical (•OH−), and
also reactingwith nitric oxide (•NO) to form thehighly reactive and very
damaging peroxynitrite anion (•ONOO−).
The presence of Fe in an environment in which H2O2 has been
released can lead to the generation of •OH− on thebasis of Fenton chem-
istry [20] (Fig. 1). The process is comprised of the oxidation of ferrous
iron (Fe2+) in the presence of H2O2 to form ferric iron (Fe3+), which
concomitantly releases a hydroxyl radical (•OH−), followed by the
reduction of the iron back to Fe2+ by the same H2O2 molecule that also
releases a proton and a hydroperoxyl radical (•OOH−) (i.e. a protonated
form of •O2−). The following reaction describes the Fenton chemistry
involved in •OH− production from H2O2 reacting with Fe2+:
Fe
2þ þ H2O2 þ H2→Fe3þ þ•OH− þ H2O
Fe
3þ þ H2O2→Fe2þ þ•OOH− þ Hþ:
In order to prevent oxidative stress generated through Fenton chem-
istry, cells have evolved the capacity to regulate iron availability through-
out the cell through speciﬁc storage components known as ferritins,
which are able to regulate the release of iron within speciﬁc compart-
ments such as the mitochondria [21]. Another protein linked with iron
homeostasis in mitochondria is frataxin, which is primarily thought to
be involved in facilitating iron–sulphur (Fe–S) cluster biogenesis. Muta-
tions that lead to the reduced expression of frataxin are strongly linked
with the neurodegenerative disease Friedreich's ataxia [22].
•O2− also readily reacts with •NO resulting in the formation of
•ONOO−, a free radical species which can have a major effect on
cellular function and health [23]. •ONOO− and its products can poten-
tially have amultitude of effects on protein, lipid, andDNA components,
either through oxidation or nitration. For instance, the essential co-
factor tetrahydrobiopterin (BH4), of the endothelial nitric oxide syn-
thase (eNOS), is highly sensitive to oxidation by •ONOO−. Loss of BH4
function through oxidative damage can lead the eNOS to generate
•O2− and contribute further to oxidative stress. This cycle of damage
to eNOS by •ONOO− is thought to be an important pathophysiological
factor in vascular disease [24]. The reaction of •ONOO− with other
molecules can also lead to the formation of more damaging ROS. An ex-
ample of this activity of •ONOO− is the reactionwith CO2 in the aqueous
phase leading to the formation of carbonate (•CO3−) and nitrogen diox-
ide (•NO2) [25]. Both •CO3− and •NO2 are potent one electron oxidants
and are thought to readily cause damage to proteins, lipids, and DNA
[23]. It is clear that the cellular elements exposed to superoxide in the
immediate environment of its generation will determine the down-
stream consequences of ROS generation.
In contrast to the damaging effects of excessive ROS production, low
levels of ROS produced bymitochondria appear to operate as important
signals involved inmaintaining cellular homeostasis and inducing stress
responses [4]. As primary components involved in oxygen utilisation,
mitochondria can also act as oxygen sensors and induce appropriate re-
sponses during hypoxic conditions. Interestingly, the mechanism that
senses low levels of oxygen is thought to typically require the release
of H2O2 by mitochondria in order to activate the transcriptional regula-
tor known as hypoxia induced factor 1α (HIF-1) [11]. Although the
HIF-1 subunit HIF-1α is constitutively expressed, it is hydroxylated by
prolyl hydroxylase (PHD) on proline residues andmarked for rapid deg-
radation during normoxia. However, H2O2 appears to inhibit this activ-
ity of PHD and thus leads to stabilisation of HIF-1α, which activates the
transcription of factors involved in hypoxic response [9]. Although the
generation of ROS (which is highly reliant on oxygen availability) may
seem paradoxical as a signal under hypoxic conditions, it may form
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Fig. 1. The path of ROS. Superoxide radicals (•O2) are typically converted to hydrogen peroxide (H2O2) by mitochondrial manganese superoxide dismutase (MnSOD). H2O2 can readily
diffuse through lipid membranes and react with a multitude of antioxidant components. At low concentrations H2O2 is most frequently converted to H2O through the activity of
peroxiredoxins (Prx-O: oxidised; Prx-R: reduced), but at higher concentrations glutathione peroxidases (GPx-O: oxidised; GPx-R: reduced) can provide additional support in facilitating
this conversion in order to deal with oxidative stress. Once oxidised by H2O2, both Prx and GPx can transfer their redox state to thioredoxins (Trx-O: oxidised; Trx-R: reduced) and
glutathione (GSSG: oxidised; GSH: reduced) respectively and are thus recycled back to a reduced state. Reduction of Trx and GSH is catalysed by thioredoxin reductase (TR2) and
glutathione reductase (GR) respectively. Catalase converts H2O2 to H2O but due to its peroxisomal location is typically functional only under increased oxidative stress conditions.
When there is a build of •O2− and H2O2 these can react with iron (Fe) according to Fenton chemistry, and generate the highly reactive and damaging hydroxyl radical (•OH−). If •O2− is
not dealt with sufﬁciently by MnSOD it can react with •NO and generate the peroxynitrite radical (•ONOO).
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less, there is some controversy surrounding this subject and in various
models of hypoxic pulmonary vasoconstriction there is evidence to sup-
port both the increase and decrease in ROS as signals for low oxygen
sensing [26]. Furthermore, the generation of H2O2 by mitochondria
has also been shown to be essential for autophagic mechanisms during
starvation conditions, as H2O2 release by mitochondria appears to play
an important role in the induction of autophagosome formation [27].
In addition to these physiological roles, low level ROS release by mito-
chondria has also been linked to the activation of stress response regu-
lators such as NF-kappa B (NFκB), JNK-1, and p53 [28–30]. In order to
effectively dealwith the contrasting effects of high and lowROS concen-
trations on mitochondrial and cellular function ROS are targeted by a
variety of components that make up antioxidant defences.2.2. ROS scavengers — the ﬁrst line of defence
Electrons released by the ETC. react with molecular oxygen (O2)
forming the superoxide radical (•O2−), which is rapidly converted to
H2O2withinmitochondria by themitochondrialmanganese superoxide
dismutase (MnSOD), also known as SOD2 (Fig. 1). Although nomutations
in SOD2 have been directly linked to a disease state, mutations in the
SOD1 gene coding for its cytoplasmic counterpart, the copper–zinc super-
oxide dismutase (CuZnSOD), are associated with familial Amyotrophic
Lateral Sclerosis (ALS), through a toxic gain of function effect [31]. An
important role of SOD is its effective dismutation of superoxide in order
to prevent its reaction with nitric oxide that leads to the formation of
the highly deleterious peroxynitrite species [23].Once •O2− is converted to H2O2 it can be sequestered and transformed
by peroxiredoxins (Prxs), glutathione peroxidases (GPxs), or catalase. In
mammalian cells there are two Prx isoforms targeted to mitochondria,
both working through the oxidation of an active cysteine site by H2O2
(Fig. 1) [32]. Subsequent reduction of the active sites by thioredoxin
(Trx) can reverse the effects of H2O2 and allow recycling of Prxs. Similarly,
Trx can also be recycled and kept in a reduced state through an NADPH
dependent reaction with the ﬂavoenzyme thioredoxin reductase. The
ability of Prxs to transfer the oxidation state to other proteins is thought
to be part of a H2O2 sensing mechanism that contributes to various
redox signalling pathways that may modulate mitochondrial processes
such as the TCA cycle, haem biosynthesis, and OXPHOS in response to
environmental changes [32,33]. There are eight GPxs foundwithinmam-
malian cells that can be oxidised by H2O2 and consequently reduced by
glutathione (GSH) [34].
Interestingly, there is always the danger that glutathione capacity
can be depleted by certain types of ROS, particularly •ONOO− and its
products [35]. This may be a major factor in the progression of patho-
physiology characterised by increased ROS leading to oxidative stress,
and highlights the importance of the GPx system in redox regulation
[23]. Similarly to Prxs, the capacity of GPxs to transfer their oxidation
state to other proteins, in this case through the S-glutathionylation of
cysteine residues on the recipient proteins, is thought to be part of sig-
nalling systems involved in the regulation of the mitochondrial redox
state [34]. Both Prxs and GPxs can function as buffers that limit H2O2 in-
duced oxidative stress, but can also function in concomitant roles as part
of signalling pathways that utilise ROS and lead to the modulation of
metabolic and biosynthetic mitochondrial processes [32,33]. Moreover,
the relative abundance of Prxs andGPxswithinmitochondria provides a
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abundance of Prx are thought to be important for converting low levels
of ROS, and as such are more likely to act as the ﬁnal receptor of low
levels of ROS associated with signalling [4]. Although GPxs have a simi-
lar activity to Prxs, they are far less abundant and cannot compete in
substrate sequestration at low levels of H2O2 [33]. While Prxs would
be most beneﬁcial under physiological conditions where low levels of
ROS must be accurately coordinated; GPxs can provide the added sup-
port required for detoxifying the radicals in higher concentrations.
Other cellular defences against mitochondrial derived ROS include
catalase, which is another enzyme that can detoxify H2O2. Catalase con-
verts H2O2 into H2O and O2 and is typically found in peroxisomes
(Fig. 1). Although not directly involved inmitochondrial function, it pro-
vides defence against oxidative stress that can be relevant to mitochon-
dria, as demonstrated by conditions where mitochondrial function
is affected by insufﬁcient or aberrant catalase functionality. Genetic ab-
normalities in catalase levels and function have been shown to be asso-
ciated with the onset of type II diabetes, suggesting an impact of the
activity of catalase upon insulin signalling [36].
Ubiquinone, or coenzyme Q (CoQ), is a vitamin like lipid soluble
molecule that features prominently in most cellular lipid membranes,
but is also found in substantial amounts in the IMM [37]. At the IMM,
CoQ functions as part of the ETC. where it facilitates transfer of electrons
from complexes I and II to complex III by undergoing a triphasic redox
cycle, known as the Q cycle, which allows it to exist in a completely
reduced (ubiquinone) or oxidised (ubiquinol) form. A concurrent role
of ubiquinone is its involvement in superoxide formation through the
Q cycle intermediate known as ubisemiquinone, which binds at the Qi
and Qo sites on complex III [9,10]. Although formation of ROS at com-
plex III in this manner is thought to have a physiological role in the
HIF-1 oxygen sensing mechanism, under most conditions it is thought
to be overshadowed by the ROS producing capacity of complex I [9].
Conversely, this redox cycling capacity also allows CoQ to function in
an antioxidant role where amongst other protective effects it can allevi-
ate lipid peroxidation [38]. Adding to the importance of CoQ in combat-
ing mitochondrial ROS is the recent development of an exogenously
derived mitochondria targeted CoQ analogue known as MitoQ10, with
in-vitro studies demonstrating that it can alleviate a variety of aberrant
phenotypes associated with increased mitochondrial ROS [34,38–41].
The capacity of CoQ to efﬁciently function as an antioxidant and the
positive effects that follow suggest that its abundance in the IMM may
have more purpose than just to function as an electron carrier in the
ETC. A major consequence of the production of damaging ROS at mito-
chondria is the peroxidation of lipids, in particular at the IMM which
contains a large amount of unsaturated fatty acids [42–45]. Such dam-
age can lead to a considerable deterioration in OXPHOS and other func-
tions of mitochondria that rely on lipid membrane composition and
integrity. As such, it is also important to acknowledge the capacity of
CoQ and the IMM as an important facilitator of antioxidant responses,
and thus an important component of mitochondrial QC.
Damage caused by oxidative stress to cellular components such as
proteins and lipids can lead to the activation of stress response pathways.
An interesting example of such a system is the Kelch-like ECH-associated
protein 1 (Keap1)–NF-E2-related factor 2 (Nrf2) signalling pathway that
increases the expression of cytoprotective genes in response to oxidative
stress [46]. Nrf2 acts as a transcriptional activator through its Cap'n'collar
(CNC) leucine zipper DNA binding region and interaction with small
Maf proteins [47]. However, Nrf2 is kept in an inactive state, bound to
Keap1, and the complex is readily ubiquitinated and degraded. A variety
of oxidative stress signals, including oxidised fatty acids, react with
Keap1 inducing a conformational change that will allow the dissociation
and activation of Nrf2 [46]. All of these antioxidant systems are a ﬁrst
line of defence against the harmful effects of ROS, but also appear to act
as regulators of their signalling activity. In both capacities they are ex-
tremely important in controlling the quality of mitochondrial function
and maintaining homeostasis and cellular health.3. Mitochondrial component control and protein homeostasis
3.1. Uptake and folding
Mitochondrial proteins not encoded by mtDNA are imported as
unfolded polypeptides through a highly selective mechanism [48].
Proteins that contain a mitochondrial targeting sequence (MTS) are
targeted to mitochondria where they are imported by the organelle in
a mitochondrial membrane potential (ΔΨm) dependent manner that
requires the activity of the outer and inner membrane translocators
(TOM & TIM respectively) [49]. The concerted action of TOM, TIM,
with the aid of chaperones and proteases, facilitates the translocation
of the pre-proteins, cleavage of the MTS, and folding of the proteins to
their native form within mitochondria [48]. The matrix localised
Hsp60 chaperonin, formed by Hsp60 and Hsp10 subunits, directs the
transport and folding and regulates the appropriate localisation of
small soluble proteins imported to mitochondria [50,51]. Hsp70 is
another matrix localised chaperone involved in protein import,
folding and complex assembly but also has a signiﬁcant role in
iron–sulphur cluster formation [52,53]. Both Hsp60 and Hsp70 are
important in protein folding and ETC. complex assembly, while
they also act in preventing the aggregation of unfolded or misfolded
proteins [54].3.2. Degradation and clearance directing
Proteins that fail to fold or assemble in thematrix or IMS are typical-
ly dealt with by an array of mitochondrial proteases. ClpXP and Lon are
matrix localised AAA proteases responsible for degrading soluble pro-
teins [55,56]. Lon has been shown to preferentially degrade certain
oxidised proteins such as aconitase [57]. Furthermore, the matrix local-
isedm-AAA and IMS localised i-AAA proteases are primarily taskedwith
degrading any misassembled or unfolded protein OXPHOS components
[58]. Mutations in the gene coding for paraplegin, a main component of
the m-AAA protease, cause the debilitating neurodegenerative disease
spastic paraplegia, highlighting the importance of the protease's func-
tion inmaintaining cellular health [59]. In addition, them-AAA protease
has been shown to inﬂuence the expression of mtDNA encoded sub-
units by controlling the processing of the nuclear encodedmitochondri-
al ribosomal protein MrpL32 during import [60].
Interestingly, recent ﬁndings show that during conditions of oxi-
dative stress there is inhibition of the processing of MrpL32 by the
m-AAA protease, which leads to a decrease in protein translationwithin
mitochondria [61]. The importance of maintaining protein populations
within mitochondria in the correct form is highlighted by themany dis-
eases associated with the loss of protein QC in the organelle [62,63]. Al-
though the clearance of dysfunctional proteins within mitochondria is
usually accomplished efﬁciently by the mitochondrial proteases, the
OMM proteins require external support. Due to the position of the
OMM in fronting the mitochondrial boundary with the cytoplasm, pro-
teins facing the cytoplasm can be processed by the cytoplasmic ubiqui-
tin proteasome system (UPS) that speciﬁcally targets and degrades
ubiquitin tagged proteins [64]. Several mitochondrial E3 ubiquitin
ligases found in the OMM are known to play a role in divergent
mechanisms such as mitochondrial dynamics, stress response, and
apoptosis [65–68]. These include resident OMM proteins such as
MARCH V/MITOL [66,69,70], MULAN/MAPL [71,72] and RNF185
[73]. Involved in sensing mitochondrial dysfunction, the cytosolic
E3 ubiquitin ligase Parkin, translocates to the OMM and is responsible
for pan ubiquitination of OMM proteins such as components of the TOM
complex (20, 40 and 70), Mfn1/2, Miro1/2 and Fis1 [74] (further
described in Section 4.2). Furthermore, a plethora of ubiquitinatedmito-
chondrial proteins have been identiﬁed through proteomic studies, sug-
gesting that the UPS is a commonly deployed degradation method for
the QC of mitochondrial proteins [75].
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(UPRmt)
Althoughmitochondrial chaperones and proteases can typically deal
with the bulk of import, folding, and degradation of proteins within mi-
tochondria, there are instances when this capacity can be overwhelmed
by demand. Increases in unfolded proteins and unassembled complexes
within mitochondria can come about either through genetic mutations
that may alter protein sequences or through environmental conditions
thatmay alter protein structure. As a response to this, themitochondrial
protein homeostasis machinery appears to be able to induce a signal
towards the nucleus in order to increase its capacity through the
mitochondrial unfolded protein response (UPRmt) [54,76]. The UPRmt
appears to be similar to another eukaryotic stress response mechanism,
the endoplasmic reticulum unfolded protein response (UPRER). Charac-
terisation of the UPRER in mammalianmodels has beenmore successful
than its mitochondrial counterpart, yet the general theme of a cellular
compartment sensing unfolded protein stress, transmitting a signal to
the nucleus, and the resulting upregulation of organelle speciﬁc chaper-
ones and proteases reﬂects and provides a precedent for the UPRmt [54].
Furthermore, downstream components utilised by the UPRER, such as
the transcription factor CCAAT-enhancer-binding protein homologous
protein (CHOP), have also been shown to be involved in UPRmt and
provide a mechanistic link between the two systems (Fig. 2). The
UPRmt system has been best characterised in the nematode worm
model Caenorhabditis elegans, but there is substantial work supporting
the existence of this system in mammalian cells. Key discoveries on
the mammalian UPRmt were made in the Hoogenraad lab where it
was demonstrated that disruption in the expression of mitochondrial
proteins led to the upregulation of speciﬁc mitochondrial chaperones
and proteases, such as Hsp60 and ClpP respectively [77,78]. Further
work demonstrated the involvement of the transcription factor CHOP,
which appears to be upregulated through Jun signalling components,
when unfolded proteins accumulate in the matrix [78,79]. Although
intermediate components of this system in mammalian cells are stillRetrograde Signalling
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mammalian retrograde responses and mitochondrial unfolded protein response (UPRmt) have no
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transcription factors including CCAAT-enhancer-binding protein homologous protein (CHOP). CH
transcription of UPRmt responsive genes containing a CHOP-C/EBPβ element. This leads to transc
activated bymitochondrial dysfunction includingmtDNA/OXPHOS defects and oxidative stress. Th
factors including RXRA, JNK2, CHOP, NKκB, Akt, mTOR and c-Myc and transcription of nuclear gelargely unknown, several insights have been gained by the elucidation
of the mechanism in C. elegans. Within this model, it is understood
that unfolded proteins accumulatingwithinmitochondria are degraded
to small peptides by the protease ClpP in the matrix, which are then
transported across the IMM by HAF-1 where they diffuse across the
OMM and into the cytosol [54]. The increased concentration of these
peptides leads to the activation of the bZip transcription factor ATFS-1
that accumulates within the nucleus [80]. Furthermore, the UBL-5 and
DVE-1 transcriptional co-factors accumulate within the nucleus due
to HAF-1 mediated peptide efﬂux from the mitochondrial matrix.
These interact with ATFS-1 and induce the expression of mitochondrial
chaperones such as Hsp60 and Hsp70 [80]. The UPRmt is an interesting
example of the interaction required betweenmitochondria and the nu-
cleus in order tomediate an appropriate response to stress generated by
abnormalities to fundamental mitochondrial components, in this case
proteins.
4. Controlling the mitochondrial cohort through
elimination — autophagy
4.1. Autophagy — a two faced process
Macroautophagy (hereon referred to as autophagy), the cellular
lysosomal degradation pathway, is a catabolic process that is essential
for homeostasis, development and survival [81]. Autophagy occurs in
almost all cells and performs a regulatory role in removing redundant/
damaged organelles and proteins. It can be up or down-regulated in re-
sponse to nutrient starvation or high metabolic demand and appears to
be downregulated in several disease states [82–84]. In addition to the
lysosome, the key component of this pathway is the autophagosome.
Nucleation and elongation of the autophagosome are reliant on several
autophagy-related (Atg) proteins that partake in ubiquitylation-like
reactions. Atg5-12 and Atg16L are involved in the elongation step of
the process while microtubule-associated protein 1 light chain (LC3;
also known as Atg8) is present in two forms; LC-I and LC3-II dependingUPR
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OP dimerises with CCAAT-enhancer-binding protein β (C/EBPβ) and binds to and promotes
ription of mitochondrial quality control genes including Hsp60/10. Reterograde signalling is
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known as LC3-I, however when proteolytically processed and covalent-
ly conjugated to phosphatidylethanolamine on the autophagosomal
membrane it is known as LC3-II [85]. The conjugation marks the matu-
ration of the autophagosome, which engulfs damaged organelles and
proteins (long half-life). The fully formed double membrane organelle
fuses with the lysosome to form the autolysosome (Fig. 3). The combi-
nation of low pH and lytic enzymes within the autolysosome degrade
organelles and proteins sequestered by the autophagosome (the inner
membrane of the autolysosome is also degraded in this process). The
resulting macromolecules can be recycled for reuse during starvation.
Although autophagy is a general term for turnover of bulk cyto-
solic components, different terms are used to describe the selectivity
of the process depending on the organelle; the endoplasmic reticulum
(ER; reticulophagy) [86,87], peroxisomes (pexophagy) [88], ribosomes
(ribophagy) [89] and mitochondria (mitophagy) [90].
4.2. Mitophagy — a highly selective form of autophagy
Although mitochondria can be non-selectively degraded by
macroautophagy, both yeast and mammalian cells have the ability
to selectively turnover damaged mitochondria though a process
called mitophagy; a more tightly regulated process than that of the
macroautophagy pathway [90,91]. Mitophagy limits activation of
the intrinsic apoptotic pathway by targeting and removing dysfunctional
mitochondria prior to permeabilisation of the outer membrane. The
initiation of this pathway is regulated at organelle level, thus allowing
for removal of a single mitochondrion. The speciﬁcity of the pathway
was ﬁrst demonstrated by using a proton ionophore (CCCP) to uncouple
the respiratory chain or photo-irradiation to depolarize individual mito-
chondria [92,93], inducing autophagic clearance of mitochondria while
leaving other organelles intact. Induction and regulation of mitophagy is
mechanistically separate from macroautophagy and involves co-
ordination of the mitochondrial morphology machinery (in particular
ﬁssion), PINK1 and Parkin and various effector proteins.Isolation 
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double membrane structure is marked by LC3-II (conjugated to phosphatidylethanolamine) on
the lytic vesicle the autolysosome. Within this compartment organelles and proteins are degraded4.3. Regulation of mitochondrial morphology— a requisite step inmitophagy
Mitochondria are dynamic organelles whose shape and size are
governed by the opposing processes of ﬁssion and fusion, operating
concurrently with organelle trafﬁcking and distribution mainly along
microtubules in mammalian cells and along the actin cytoskeleton in
yeast. This balance maintains and controls the inheritance and trans-
mission of mtDNA, metabolite levels and energy transduction [94].
Mitochondrial morphology is regulated by a conserved family of large
GTPases in both the inner and outer membranes [95]. Optic atrophy 1
(Opa1, Mgm1 in yeast) maintains and controls inner membrane fusion
and cristae integrity, while fusion of the outer membrane is largely
under control of the two mitofusins (Mfn1 and Mfn2, Fzo1 in yeast)
[96,97]. Like fusion, ﬁssion is also controlled by a large GTPase, dynamin
related protein 1 (Drp1/Dlp1, Dnm1p in yeast). Drp1 is a largely cytosol-
ic protein that cycles on and off the mitochondrial outer membrane,
only present on the mitochondrial surface in multimeric structures
when required for scission of the organelle [98]. Although the exact
mechanism of Drp1 recruitment to the outer membrane remains elu-
sive, new receptor/adaptor molecules have been proposed (Mff and
MiD49/51), however further mechanistic clariﬁcation is required to as-
certain how these proteins mediate this process [99,100].
Modulation of mitochondrial shape is one of many important steps
in mitophagy and has been proven by manipulation of pro-ﬁssion pro-
teins Fis1 and Drp1 and appearance of fragmented mitochondria prior
tomitophagy [101]. Knockdownof Fis1 or overexpression of a dominant
negative form of Drp1 (Drp1K38A) results in almost complete fusion of
themitochondrial network [101], reducingmitochondrial sequestration
by autophagosomes. In keepingwith this, many studies have linked the
rate of mitophagy to the size of mitochondria. Mitochondria visualized
within autophagosomes have been reported to be b1 μm in diameter
[101–104]. However this is not seen uniformly, making it complex to
delineate. Both, overexpression of Opa1 (resulting in a fragmented
network) and inhibition of ﬁssion (a tubular, extended network) in
INS1 cells, result in a ~70% reduction in mitophagy rates [101]. Theseme
lar
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limiting step in mitophagy.
What is clear however, is the involvement of both division and
fusion of mitochondria leading up to mitophagy. In contrast to ﬁssion,
fusion requires an intact membrane potential (ΔΨm) and is thus selec-
tive. Termed ‘kiss-and-run’ events these are brief fusion events followed
by ﬁssion of the organelle. These events often result in daughter mito-
chondria of unequal ΔΨm [101]. This single event is enough to trigger
induction of mitophagy that degrades the daughter organelle with a
lower potential. However, if the mitochondrion can recover its ΔΨm, it
can re-enter the ﬁssion/fusion cycle [101]. This suggests that mitochon-
drial ﬁssion, which is often a cellular response to stress, is a mechanism
utilised by the cell to segregate and eliminate damaged mitochondria
from an otherwise healthy network.4.4. PINK1 and Parkin
Mutations in PTEN-induced kinase (PINK1) and Parkin can cause
familial Parkinson's disease [105,106]. These proteins are key regulators
inmitophagy, placing this pathway ﬁrmly on themap in the pathophys-
iology of Parkinson's disease. PINK1 is a mitochondrial serine/threonine
kinase encoded by the PARK6 locus, while Parkin is cytosolic E3 ubiqui-
tin ligase encoded by PARK2. PINK1 contains a canonical N-terminal
mitochondrial targeting signal, followed by a transmembrane domain
and a putative kinase domain at the C-terminus. Parkin contains a
ubiquitin-like domain at theN-terminus followed by two RINGdomains
(RING1 and RING2), an in-between domain and a third RING domain.
This C-terminus section is termed the RING in-between RING (RBR)
domain and contains the E3 ubiquitin ligase activity and HECT (homolo-
gous to the E6-AP carboxyl terminus)-like E3 activity. It has recently
been shown that the dormant HECT-like domain of Parkin is activated
by PINK1 and this activation is required for Parkin recruitment to mito-
chondria, and subsequent induction of mitophagy [107].
These proteins function in the same pathway with PINK1 acting
upstream of Parkin. PINK1 is imported into the mitochondria in a ΔΨm
dependent manner where it is cleaved by PARL in the IMM, restricting
its expression (Fig. 4) [108–110]. This is a regulatory checkpoint in normal
cell homeostasis. Upon dissipation ofΔΨm, PINK1 import is inhibited and
thus accumulates on the OMM, where it is trapped at the TOM complex
[111]. PINK1 recruits Parkin and induces its ligase activity [112].
Ubiquitination of OMMproteins, Mfn1/2, components of the TOM com-
plex (20, 40, 70) and VDAC1 complete the induction of mitophagy by
the PINK1/Parkin pathway (Fig. 4) [74,113,114]. Site-speciﬁc mutation
(C431) of Parkin has recently been shown to alter the ubiquitination
patterns of proteins on the OMM [115]. Interestingly, it was also
shown that there are no discernible sequence motifs common to pro-
teins ubiquitinated by Parkin. This suggests that Parkin speciﬁcity is pri-
marily determined by recruitment to the OMM and/or proximity to
other proteins. Further supporting this, all modiﬁcations by Parkin to
OMM proteins occur on the cytoplasmic face of the targeted protein
[115]. Ubiquitination of the mitofusins appear to be of particular rele-
vance as degradation of these proteins insures segregation of dysfunc-
tional mitochondria, as there is no functional mechanism to tether
adjacent mitochondria for fusion events.
The ubiquitin activity of Parkin is thought to be lysine-63 (K-63)
mediated [74]. This polyubiquitination recruits p62, also called sequesto-
some 1 (SQSTM1) to the OMM. p62/SQSTM1 is thought to be an autoph-
agy adaptor — although its role remains controversial. The protein has a
K-63 ubiquitin binding domain in addition to an LC3-binding domain,
thus it appears to have a role in recruiting autophagosomes to mito-
chondria [116]. Some reports detail a decrease inmitophagy upon knock-
down of p62/SQSTM1 suggesting that it is limiting step in the process
[117,118]. Conversely it has also been reported that p62/SQSTM1 medi-
ates aggregation of damagedmitochondria, similar to the role it performs
with polyubiquitinated proteins in the cytosol [119].There are two sides to the process of autophagy/mitophagy. The ﬁrst
is a protective measure ensuring the removal of damaged organelles/
proteins from the cell. However this process can be downregulated in
disease states and in many cases can contribute to the pathogenesis of
the disorder [83,84,120–122]. Although all the speciﬁcs of the process
are not fully understood, the precise execution of autophagy and
mitophagy pathways is clearly vital for cellular homeostasis.
5. Communications between the nucleus and mitochondria
5.1. Biogenesis and the control of mitochondrial capacity through
transcription
Nuclear transcription controls mitochondrial function, ultimately
coordinating the function and capacity of the organelle in response to
intrinsic and extrinsic signals. The coordinated increase inmitochondri-
al mass and bioenergetic capacity is termed biogenesis. Activation of
biogenesis can occur for many reasons, including alterations to the cell's
redox state, nutrient deprivation, and (in muscle) exercise [123–125].
An array of transcription factors (TFs) activates and coordinates the ex-
pression of nuclear andmitochondrial geneswith additional levels of con-
trol implemented through co-activators [126,127]. Nuclear respiratory
factor 1 (NRF-1) and NRF-2 are the principal TFs associated with biogen-
esis. These TFs control the expression of key mitochondrial components
involved in OXPHOS, haem biosynthesis, the function and regulation of
mtDNA, and antioxidant defences [127]. Other TFs involved in the regula-
tion of mitochondrial genes are the oestrogen related receptor (ERRα),
the cAMP response element (CREB), and the Ying Yang 1 (YY-1) tran-
scription factor. While ERRα regulates oxidative metabolism through
its control of β-oxidation related genes [128], CREB and YY-1 are in-
volved in the expression of ETC. protein components [129,130]. Although
these transcription factors are directly responsible for the expression of
mitochondrial proteins in the nucleus, higher level organisation through
transcriptional co-activators integrates the TFs into the programme of
biogenesis.
The peroxisome proliferator-activated receptor (PPAR) protein
family includes one of the most studied regulators of biogenesis
known as PPAR γ (gamma) co-activator 1α (PGC1α) [127]. PGC1α is
considered a master regulator of biogenesis due to its crucial multidi-
mensional role in the activation and regulation of transcription of nucle-
ar encoded biogenesis factors [125]. It has two structural homologues
known as PGC1β and PGC1 related co-activator (PRC). PGC1α and
PGC1β exhibit a certain degree of complementarity in function and
their expression is substantially increased under conditions requiring
improved energy transduction through increased mitochondrial con-
tent [127]. Although PRC exerts control over a similar set of TFs to the
other two homologues, it is thought to regulate biogenesis in re-
sponse to different metabolic cues and stress signals [131]. Activa-
tion of PRC has been observed as a result of oxidant stress linked
to inﬂammatory reactions and the premature induction of senescence
[132]. This divergence in stress conditions capable of activating PRC sug-
gests that it acts as a general regulator of adaptive responses to cellular
dysfunction [132].
In addition to increasing the transcription of nuclear encoded mito-
chondrial genes, activation of biogenesis also increases the transcription
of mtDNA encoded genes. The process of mitochondrial transcription
requires the nuclear encoded RNA polymerase POLRMT, the transcrip-
tion initiation factor TFB2M, the transcriptional stimulatory factor
TFAM, and the termination factorsMTERFs [15,133]. These factors coop-
erate in order to generate long polycistronic RNA precursor molecules
from each strand of the plasmid like mtDNA. The polycistronic long
RNA is subsequently processed to generate the mitochondrial rRNAs
(mt-rRNA), mitochondrial tRNAs (mt-tRNA), and mitochondrial mRNAs
(mt-mRNA) required for protein translation [134]. Apart from the
rRNAs, tRNAs, and mRNAs, all other components of the mitochondrial
translation machinery are nuclear encoded, however the process of
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mitochondrial biogenesis is the potential for increased replication of
mtDNA leading to an increase in mtDNA copy number. The replication
of mtDNA is facilitated by the mitochondrial DNA polymerase gamma
(POLG), which also exhibits repair activity [17,135]. Mutations in POLG,
which lead to aberrant functionality are responsible for numerousdisease phenotypes including Alper's syndrome and Progressive
external ophthalmoplegia (PEO) [135,136]. A critical stage in the ex-
pression of mtDNA encoded proteins is their co-assembly with other
subunits, including those that are nuclear encoded, into the OXPHOS
complexes in the IMM. In order to facilitate assembly of the holoen-
zymes that constitute the OXPHOS machinery, a group of proteins
1262 V.N. Kotiadis et al. / Biochimica et Biophysica Acta 1840 (2014) 1254–1265known as ‘assembly factors’ orchestrate the correct formation of
complexes, in a manner that is subject to a strict stoichiometric
balance of protein subunits [137,138]. Problems arising with the as-
sembly of complexes can lead to numerous mitochondrial diseases
and highlight the importance of mitochondria to nucleus communi-
cation and interaction [139].
The modulation of mitochondrial capacity through the function
of the PGC1 family and the process of biogenesis allows cells to
respond to a variety of conditions requiring an increase in ATP transduc-
tion by utilising the highly efﬁcient process of OXPHOS. Moreover, the
effectiveness of the PGC1 family in dealing with conditions requiring
increasedmitochondrial capacity is highlighted by the therapeutic prom-
ise exhibited by induction of biogenesis through this system in models
of ageing, neurodegeneration, and myopathies [125]. Nevertheless, the
process of biogenesis is complex and relies on the effectiveness of a
multitude of factors that will cooperate in order to bring about the efﬁ-
cient expression of proteins and assembly of macromolecular complexes
in the mitochondria.
5.2. Retrograde signalling — when mitochondria talk back
The increased expression of nuclear encoded genes in response to
altered mitochondrial bioenergetic state, compensating the effects of
mitochondrial dysfunction or stress, is known as retrograde signalling
(Fig. 2). Retrograde responses are not strictly considered part of mito-
chondrial QC systems, but are rather stress response pathways comple-
mentary to mitochondrial QC that activate mechanisms that tend to
counter bioenergetic deﬁciencies caused by mitochondrial dysfunction
[19]. Although a dedicated signalling pathway that performs this
function has not yet been established in mammalian cells, studies in
yeast have provided interesting observations on the workings of such
a system. In yeast, perturbations to mitochondria such as the loss of
mtDNA (i.e. petite or rho0 cells) lead to the activation of transcription
by a factor comprised of the RTG1, RTG2, and RTG3 (RTG1–3) proteins
[19]. Representative changes in metabolic function induced by retro-
grade signalling in yeast include the activation of the glyoxylate cycle
and the upregulation of fatty acid β-oxidation [19]. These changes
alter mitochondrial metabolism towards a greater variety of carbon
sources, such as acetate, compensating for a reduction in capacity or
lack of OXPHOS. Another interesting alteration to cell function in the
yeast retrograde signalling model is the characteristic inactivation of
TORC1, the yeast homologue of mTORC1 [140]. Active TOR signalling
is a negative regulator of retrograde signalling components, while retro-
grade signalling activation and recruitment of the RTG factors inhibits
TOR signals. Involvement of TOR signalling in the retrograde signalling
pathway highlights the potential for the conservation of such a retro-
grade signalling system in higher eukaryotes. TOR signalling is itself
highly conserved from yeast to humans and, although its sphere of ac-
tivity may be slightly changed between species [141], its involvement
may hint at the conservation of a retrograde signalling pathway.
In metazoans evidence for a retrograde signalling pathway has
mainly been observed in the worm C. elegans, where its activation has
been shown to extend lifespan [142,143]. In a study where life span
was increased following RNAi mediated downregulation of COX4 (sub-
unit 4 of cytochrome oxidase complex IV), there was a concomitant
activation of the UPRmt [144]. UBL-5 and DVE-1 were also required for
the changes in nuclear transcription, suggesting interconnectedness be-
tween themany systems that facilitatemitochondrial to nucleus commu-
nication. Moreover, it supports a link between retrograde signalling and
more traditional mitochondrial QC systems like the UPRmt. Evidence of
retrograde signalling in metazoans has also started to surface from
model systems such as theﬂyDrosophilamelanogaster [145,146]. Inmam-
malian model systems there are also some indications of retrograde sig-
nalling surfacing from studies in mice [147–149]. Results from these
model systems demonstrate characteristic increases in life span. Howev-
er, in the case of mammalian retrograde signalling, the pathway utilisedfor transducing the signal towards the nucleus and activating expression
will be different from the RTG factors observed in yeast [19].
Although the exact pathway that may be utilised by a mammalian
retrograde response still remains unknown, various evidence suggest
that NFκB stress responses inmammalian cells resemble those observed
as part of retrograde signalling in lower eukaryotes [150]. A recent study
suggested that mitochondrial dysfunction caused by a speciﬁc mtDNA
mutation, namely the A3243G base substitution principally associated
with the mitochondrial encephalomyopathy lactic acidosis and stroke-
like episodes (MELAS) clinical phenotype, leads to the activation of ret-
rograde signalling in a mtDNA mutation cybrid model cell line [151].
Microarray data from cells containing mtDNA mutations suggests that
the activation of systems relating to the observed retrograde response
may be mediated through c-Jun/JNK pathway, as well as some involve-
ment of RXRA. Both NFκB and c-Jun are rapid acting transcriptional
regulators that do not require new protein synthesis in order to be acti-
vated. Such a rapid activationwould be ideal in dealingwith high prior-
ity stress signals such as those generated as part of mitochondrial
retrograde signalling (Fig. 2).
5.3. The importance of genomes — nucleus and mtDNA compatibility
The ability of the mitochondrial genome to communicate and func-
tion synergistically with nuclear expression appears to also be deter-
mined by speciﬁc sequence alterations that categorise mtDNA in
haplogroups. Extensively used to trace maternal phylogenetic lineages,
mtDNA haplotypes also appear to have a considerable impact upon mi-
tochondrial function [152]. Variations in mtDNA are speciﬁcally associ-
ated with disease phenotypes with speciﬁc sequence alterations in
mitochondrial components that may generate measurable effects on
bioenergetic and other functional aspects of the organelle, such as a de-
crease in respiratory function [153]. There are amultitude of pathogenic
mutations reported in human mtDNA that associate with divergent
clinical phenotypes [8], with a typical example being the A3243Gmuta-
tion in the gene encoding mitochondrial tRNALeu [154]. Although the
A3243G mutation is usually associated with the clinical phenotype
known asMELAS it can also underpin the development of other clinical
phenotypes. The multitude of pathological phenotypes that can arise in
patients carrying the A3243Gmutation stems from the fact that themu-
tation has a generic effect on the process of translation and protein pro-
duction of mitochondrial components [8]. Nevertheless, it is clear that
the same mutation can cause very different phenotypes between pa-
tients and an important variable that separates individual cases is the
nuclear background. In fact substantial variation in mitochondrial func-
tion can also occur even when the sequence changes are not classically
pathogenic. Elegant work by theWallace lab has demonstrated how the
balance of different haplotypes of mtDNA that are divergent due to
polymorphisms in their DNA sequence, also known as heteroplasmy,
can have a profound effect on cell physiology and can lead to substantial
cognitive alterations in a mouse model [155]. Moreover, the different
species of mtDNA in this study did not carry pathogenic mutations but
innocuous alterations to the sequence, indicating that variation in
mtDNA can impact uponmore than just the expression of mitochondri-
al components. It is becoming clear that a certain amount of interaction
between the nuclear and mitochondrial genomes occurs at a level not
observable through our current understanding of biology. Yetmismatch
between the two genomes results in observable effects upon the quality
of mitochondria and cellular health. This suggests that the relationship
between nuclear and mitochondrial genome backgrounds, which is
most likely the result of co-evolutionary adaption between the two ge-
nomes, may potentially play a key role in health and disease.
6. Concluding remarks
Through this review we have explored some major aspects regard-
ing the maintenance of mitochondrial ﬁtness. Classical mitochondrial
1263V.N. Kotiadis et al. / Biochimica et Biophysica Acta 1840 (2014) 1254–1265QC systems such as mitophagy and mitochondrial protein homeostasis,
appear further enhanced and supported by mitochondrial stress re-
sponse systems. All of these systems ultimately have a substantial effect
on mitochondrial function, but may also be harnessed to correct mito-
chondrial dysfunction. Further exploration of these systems and better
understanding of how they work, what activates, and what inhibits
them, may ultimately provide us with methods to alleviate pathophys-
iological problems relating to aberrant mitochondrial function. To this
effect themitochondrion is now emerging as a target for therapeutic in-
terventions that encompass small molecules, transcriptional regulation,
and genetic manipulation, offering exciting opportunities to treat a di-
verse range of diseases.
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